Drug repositioning for personalized medicine

by Li, Yvonne Y, Jones, Steven JM
Published 2012

A Computational Approach to Finding Novel Targets for Existing Drugs

by Li, Yvonne Y., An, Jianghong, Jones, Steven J. M.
Published 2011

Improving the specificity of high-throughput ortholog prediction

by Fulton, Debra L, Li, Yvonne Y, Laird, Matthew R, Horsman, Benjamin GS, Roche, Fiona M, Brinkman, Fiona SL
Published 2006

Ligand associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3 dependent cancer cells

by Wang, Jun, Mikse, Oliver, Liao, Rachel G., Li, Yvonne, Tan, Li, Janne, Pasi A., Gray, Nathanael S., Wong, Kwok-kin, Hammerman, Peter S.
Published 2014

Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)

by Reipas, Kristen M., Law, Jennifer H., Couto, Nicole, Islam, Sumaiya, Li, Yvonne, Li, Huifang, Cherkasov, Artem, Jung, Karen, Cheema, Amarpal S., Jones, Steven J.M., Hassell, John A., Dunn, Sandra E.
Published 2013

Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing

by Parker, Jeremy D.K., Shen, Yaoqing, Pleasance, Erin, Li, Yvonne, Schein, Jacqueline E., Zhao, Yongjun, Moore, Richard, Wegrzyn-Woltosz, Joanna, Savage, Kerry J., Weng, Andrew P., Gascoyne, Randy D., Jones, Steven, Marra, Marco, Laskin, Janessa, Karsan, Aly
Published 2016

Genomic analysis of a rare human tumor

by Jones, Steven JM, Laskin, Janessa, Li, Yvonne Y, Griffith, Obi L, An, Jianghong, Bilenky, Mikhail, Butterfield, Yaron S, Cezard, Timothee, Chuah, Eric, Corbett, Richard, Fejes, Anthony, Griffith, Malachi, Yee, John, Martin, Montgomery, Mayo, Michael, Melnyk, Nataliya, Morin, Ryan D, Pugh, Trevor J, Severson, Tesa, Shah, Sohrab P, Sutcliffe, Margaret, Tam, Angela, Terry, Jefferson, Thiessen, Nina, Thomson, Thomas, Varhol, Richard, Zeng, Thomas, Zhao, Yongjun, Moore, Richard A, Huntsman, David G, Birol, Inanc, Hirst, Martin, Holt, Robert A, Marra, Marco A
Published 2010

Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers

by Laskin, Janessa, Jones, Steven, Aparicio, Samuel, Chia, Stephen, Ch'ng, Carolyn, Deyell, Rebecca, Eirew, Peter, Fok, Alexandra, Gelmon, Karen, Ho, Cheryl, Huntsman, David, Jones, Martin, Kasaian, Katayoon, Karsan, Aly, Leelakumari, Sreeja, Li, Yvonne, Lim, Howard, Ma, Yussanne, Mar, Colin, Martin, Monty, Moore, Richard, Mungall, Andrew, Mungall, Karen, Pleasance, Erin, Rassekh, S. Rod, Renouf, Daniel, Shen, Yaoqing, Schein, Jacqueline, Schrader, Kasmintan, Sun, Sophie, Tinker, Anna, Zhao, Eric, Yip, Stephen, Marra, Marco A.
Published 2015

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

by Koyama, Shohei, Akbay, Esra A., Li, Yvonne Y., Herter-Sprie, Grit S., Buczkowski, Kevin A., Richards, William G., Gandhi, Leena, Redig, Amanda J., Rodig, Scott J., Asahina, Hajime, Jones, Robert E., Kulkarni, Meghana M., Kuraguchi, Mari, Palakurthi, Sangeetha, Fecci, Peter E., Johnson, Bruce E., Janne, Pasi A., Engelman, Jeffrey A., Gangadharan, Sidharta P., Costa, Daniel B., Freeman, Gordon J., Bueno, Raphael, Hodi, F. Stephen, Dranoff, Glenn, Wong, Kwok-Kin, Hammerman, Peter S.
Published 2016